Ghiath M. Sukhtian bought $2.5M of OTLK stock

Ghiath M. Sukhtian, Dir, 10% of Outlook Therapeutics, Inc. (OTLK), bought 2,525,252 shares of OTLK stock worth $2.5M, per an SEC Form 4 filed Aug 14, 2026.

The shares came through a private deal, not the open market.

The trade happened on Aug 12, 2026, 2 days before it was made public.

OTLK has moved -62.5% since the trade date, from $1.10 to $0.41 (Nov 13, 2026 close).